Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective, Crossover, Randomized, Double-blind Study for the Compliance and Efficacy of Kynex and Kynex3 in Dry Eye Patients
KCT0004912Phase 4Not yet recruiting
- Sponsor
- Alcon Inc.
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Kynex in dry eye syndrome (DED), sponsored by Alcon Inc.. Planned start May 2020; status: not yet recruiting.
02
Drugs
Kynex
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0004912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004912.